Country accounts for over 20% of global production with $20 billion exports forecast by 2020
Shri Ravi Udaya Bhaskar, Director General, Pharmexcil, commented: “A key driver for this growth is India’s extensive product portfolio, which provides the capability to manage and treat any ATC (Anatomical therapy classification) – to the same quality as the innovators – at highly affordable costs.“
Shri Ravi Udaya Bhaskar, added:“The industry has been working diligently towards enhancing its capabilities and strengths. This includes its more than 950 colleges, which deliver over 90,000 pharmaceutical graduates per year, of which, 30,000 have completed master’s degrees. Moreover, Government’s policies are directed at increasing infrastructure facilities to help enable manufacturing to reach its highest potential – with pharma exports expected to reach $20 billion by 2020.”
Corporate Comm India(CCI Newswire)
Visakhapatnam, September 28, 2024: MGM Healthcare, one of India’s leading healthcare institutions, proudly announces its…
Hyderabad, September 28, 2024: In a heartfelt initiative to mark World Heart Day, CARE Hospitals, one…
By Dr. Anoop P, Sr. Consultant - Haematology, Haemato-Oncology, Paediatric Haemato-Oncology & Bone Marrow Transplant,…
By Dr. Priyanka Kuri, Consultant – Dermatology, Aster Whitefield Hospital, Bengaluru Your skin not only…
24x7 Heart Tracking Anytime, Anywhere for Proactive Cardiac Care and Early Intervention on MediBuddy Platform…
Indore, September 25, 2024: Celebrated aromatherapy pioneer and skin care expert, Dr. Blossom Kochhar, successfully unveiled…